The cardiovascular system and antidepressive drugs
Stazi, C.; Stazi, F.
La Clinica Terapeutica 137(2): 125-135
1991
ISSN/ISBN: 0009-9074 PMID: 1828405 Document Number: 379555
The authors consider the ever-increasing number of depressed patients, related to the stress of modern life and to the prolongation of life span. They stress that these patients are often cardiopathic or impaired by the senile heart. Finally they illustrate the cardiovascular effects of antidepressant drugs and how to avoid them.
Document emailed within 1 workday
Related Documents
Náhunek, K.; Svestka, J.; Rodová, A. 1971: To the antidepressive properties of lithium and its place in the group of antidepressive drugs Activitas Nervosa Superior 13(3): 169-170Beresewicz, M.; Bidzińska, E.; Koszewska, I.; Puzyński, S. 1991: Results of using tricyclic antidepressive drugs in the treatment of endogenous depression (comparative analysis of 7 drugs) Psychiatria Polska 25(3-4): 13-18
Anibaldi, A.; Santin, L.; Scalercio, A.; Stella, S. 1982: Toxic effects of drugs on the cardiovascular system Minerva Pediatrica 34(5): 215-224
Sato, Y. 2003: Safety evaluation of drugs on the cardiovascular system by the analysis of gene expression Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku 121: 112-114
Wehrlin, N. 1973: Antidepressive drugs or thymoanaleptics Revue de l'Infirmiere 23(9): 887-892
Zavrsnik, D.; Spirtović, S.; Becić, F. 2006: Antidepressives and antidepressive interactions with other drugs Medicinski Arhiv 60(1): 63-67
Fossati, C.; Giustiniani, S. 1985: Cardiotoxicity caused by the use of antidepressive drugs La Clinica Terapeutica 115(6): 491-495
Bernardo, M. 1997: Antidepressive drugs: yesterday, today and tomorrow? Medicina Clinica 108(5): 180-181
Kunz, R.; Leuthold, A.; Buddeberg, C. 1998: Sexual dysfunctions with antidepressive drugs--results of a physician survey Praxis 87(18): 610-616
Puech, A. 1994: The significance of evaluating animal behavior with psychotropic drugs and especially with antidepressive agents L'Encephale 20(Special Issue 2): 247-249
Llop, C.; Ribas, J.; Rovira, E. 1998: Estimation of the prevalence of depression from the daily defined doses of antidepressive drugs Medicina Clinica 110(14): 557-558
Misurec, J. 1971: EEC frequency analysis in the treatment with some antidepressive drugs (imipramine, amitriptyline, dibenzepine, dimethacrine) Activitas Nervosa Superior 13(3): 218-219
Sindrup, S.H. 1990: Drug therapy of symptoms in peripheral diabetic neuropathy. Tricyclic antidepressive agents and other drugs Ugeskrift for Laeger 152(8): 554-556
Helmchen, H.; Hippius, H.; Rosenberg, L. 1971: Double-blind study of 3 antidepressive drugs. 1. General notes on methods and evaluation principles, with special consideration of the dropout problem Arzneimittel-Forschung 21(5): 629-635
Bangalee, V; Suleman, F 2016: Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa? Health Sa Gesondheid 21: 60-66
Panicker, G.K.; Karnad, D.R.; Salvi, V.; Kothari, S. 2012: Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs Journal of the Association of Physicians of India 60: 56-61
Zakusov, V.V. 1971: Effect of tranquilizing and antidepressive agents on the summation of impulses in the central nervous system Farmakologiia i Toksikologiia 34(1): 7-9
Koszewska, I.; Puzyński, S. 1991: Transition from the depressive stage to the manic stage during the treatment with antidepressive drugs Psychiatria Polska 25(3-4): 76-82
Makar, O.; Siabrenko, G. 2018: Influence of Physical Activity on Cardiovascular System and Prevention of Cardiovascular Diseases (Review) Georgian Medical News 2018(285): 69-74
Weser, C.; Klessen, D. 1978: Strategy for the control of cardiovascular diseases in a metropolis (demonstrated by the Berlin concept of a unified system of care for patients with cardiovascular diseases) Zeitschrift für Arztliche Fortbildung 72(20): 967-971